MedPath
HSA Approval

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

SIN06429P

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

July 8, 1991

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA30

combinations of electrolytes

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MEDICAL INDUSTRIES SDN BHD

B. Braun Melsungen AG

B. Braun Medical SA

Active Ingredients

CALCIUM CHLORIDE

0.027 g/100 ml

Calcium chloride

POTASSIUM CHLORIDE

0.04 g/100 ml

Potassium chloride

SODIUM CHLORIDE

0.6 g/100 ml

Sodium chloride

SODIUM LACTATE

0.312 g/100 ml

Lactic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.